September 10, 2024

Genitourinary Cancer Linked to Increased Risks in Families

A recent study in Cancer reveals that relatives of genitourinary cancer patients face increased risks of psychological issues and cardiovascular disease within the first year of diagnosis, with variations based on cancer type and patient proximity.

Conexiant

September 09, 2024

Bariatric Surgery Outperformed Meds for Hypertension Control

Meta-analysis reveals bariatric surgery patients 7 times more likely to reduce antihypertensive medications compared to conventional treatment.

Conexiant

September 09, 2024

Cruciferous Veggies Lowered BP in Mild Hypertensives

Consuming 300g of cruciferous vegetables daily for two weeks reduced 24-hour systolic blood pressure by 2.5 mmHg in adults with mild hypertension, a randomized crossover trial found.

Conexiant

September 06, 2024

Lower Potassium Threshold Noninferior for AF Prevention After Surgery

A new clinical trial found that supplementing potassium only when levels fall below 3.6 mEq/L, rather than maintaining levels above 4.5 mEq/L, was just as effective in preventing atrial fibrillation after cardiac surgery, while also reducing costs.

Conexiant

September 03, 2024

Wearable AF Screening: More Diagnoses, No Stroke Reduction

Wearable ECG screening boosted AF diagnoses by 52% but failed to reduce stroke hospitalizations in the GUARD-AF trial, challenging assumptions about AF screening's impact on stroke prevention.

Conexiant

September 03, 2024

Biomarkers Predict 30-Year Heart Risk in Women

A single baseline measure of three biomarkers predicted cardiovascular events in women over 30 years, with those in the highest quintile for all three markers facing a 2.63-fold increased risk.

Conexiant

September 03, 2024

Obesity-CVD Link Spotlighted in ESC Report

Two-thirds of obesity-related deaths linked to cardiovascular disease, doubling global obesity prevalence in four decades.

Conexiant

September 03, 2024

Semaglutide Lowers CV Events and Mortality Across HF Subtypes in Obese Patients

A study published in The Lancet found that semaglutide may reduce major adverse cardiovascular events and all-cause mortality in patients with obesity and heart failure, regardless of heart failure subtype.

Conexiant

August 30, 2024

Quit Smoking, Halve Heart Attack Risk: Study

Quitting smoking post-CAD diagnosis cut risk of major cardiovascular events by 44% in international study of over 32,000 patients.

Conexiant